Home Sun Pharma and Merck & Co. Inc. Enter into Licensing Agreement for Tildrakizumab
 

Keywords :   


Sun Pharma and Merck & Co. Inc. Enter into Licensing Agreement for Tildrakizumab

2014-09-17 14:30:00| Merck.com - Corporate News

Dateline City: WHITEHOUSE STATION, N.J., and MUMBAI, India WHITEHOUSE STATION, N.J., and MUMBAI, India--(BUSINESS WIRE)--Merck & Co., Inc., (NYSE:MRK), known as MSD outside the United States and Canada, and Sun Pharmaceutical Industries Ltd. Language: English Contact: MerckMedia:Ian McConnell, 908- 423-3046Investor:Justin Holko, 908-423-5088orSun PharmaMedia:Frederick Castro, +91-22-66455964Investor:Nimish Desai, +91-22-66455717 Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: 524715 Exchange: MUMBAI read more

Tags: for enter agreement sun

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
27.11
27.11240
27.11 C.J.Date
27.11VR7001
27.11BEAST
27.11
27.11
27.11 112
More »